A carregar...
Progress of EGFR-TKI and ALK/ROS1 inhibitors in advanced non-small cell lung cancer
To discuss the mechanism and clinical application of EGFR-TKI and ALK/ROS1 inhibitors in non-small cell lung cancer (NSCLC), we reviewed recent available data mainly from PubMed. We found that chemotherapy, progression-free survival (PFS), objective response rate (ORR), and quality of life of patien...
Na minha lista:
| Publicado no: | Int J Clin Exp Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565207/ https://ncbi.nlm.nih.gov/pubmed/26379824 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|